Filtered By:
Management: Marketing
Countries: India Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 144 results found since Jan 2013.
A history of thalidomide in India
This article challenges this view by showing that the drug entered the Indian subcontinent through the former Portuguese territory of Goa around 1960. We examine the subsequent development of its distribution, use and regulation in India from the mid-1960s up to the present situation. Colonial legacies are a crucial explanation for the early appearance of thalidomide on the Indian subcontinent. They also influenced its re-emergence as drug for treating leprosy reactions in India after 1965. We identify key actors in this process: the original German producer that delivered thalidomide free of charge, European doctors who w...
Source: Medical History - September 5, 2023 Category: History of Medicine Authors: Ludger Wimmelb ücker Anita Kar Source Type: research
A deep-SIQRV epidemic model for COVID-19 to access the impact of prevention and control measures
This article proposes an artificial intelligence(AI) based intelligent prediction model called Deep-SIQRV(Susceptible-Infected-Quarantined-Recovered-Vaccinated) to simulate the spreading of COVID-19. While many models assume that vaccination provides lifetime protection, we focus on the impact of waning immunity caused by the conversion of vaccinated individuals back to susceptible ones. Unlike existing models, which assume that all coronavirus-infected individuals have the same infection rate, the proposed model considers the various infection rates to analyze transmission laws and trends. Next, we consider the influence ...
Source: Computational Biology and Chemistry - August 25, 2023 Category: Bioinformatics Authors: Aakansha Gupta Rahul Katarya Source Type: research
Marketing strategies for waste recycling: a bibliometric analysis towards the circular economy
Environ Sci Pollut Res Int. 2023 Apr 28. doi: 10.1007/s11356-023-27040-y. Online ahead of print.ABSTRACTCompanies have adopted green marketing and marketing strategies to position themselves in consumer preferences and combat the problem of accelerated consumption of resources that has compromised the planet's regenerative capacity, where the circular economy emerges as a solution to move towards responsible production and consumption patterns. From waste recycling marketing strategies, a descriptive analysis of 120 documents from the SCOPUS database was carried out using bibliometric techniques to know the existing state ...
Source: Environmental Science and Pollution Research International - April 28, 2023 Category: Environmental Health Authors: Shunashi Yectzin Aguilar-Morales Mariana Negrete-Cardoso Genoveva Rosano-Ortega Francisco Javier S ánchez-Ruíz Laura Berenice S ánchez-Baltasar Carlos Arturo Vega-Lebr ún Pablo Samuel Schabes-Retchkiman Source Type: research
Weekly Australian Health IT Links – 10 October, 2022.
Here are a few I have come across the last week or so. Note: Each link is followed by a title and a few paragraphs. For the full article click on the link above title of the article. Note also that full access to some links may require site registration or subscription payment.General Comment-----Lots of stuff this week – with Optus still causing trouple-----https://www1.racgp.org.au/newsgp/professional/doh-releases-30-20-rule-fact-sheetDoH releases 30/20 rule fact sheetThe new telehealth compliance measure came into effect on 1 October, despite calls to delay its implementation.The 30/20 rule limits the number of MBS it...
Source: Australian Health Information Technology - October 10, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs
Commentators and Journalists Weigh In On Digital Health And Related Privacy, Safety, Social Media And Security Matters. Lots Of Interesting Perspectives - August 23, 2022.
-----This weekly blog is to explore the news around the larger issues around Digital Health, data security, data privacy, AI / ML. technology, social media and related matters.I will also try to highlightADHA Propagandawhen I come upon it.Just so we keep count, the latest Notes from the ADHA Board were dated 6 December, 2018 and we have seen none since! It ’s pretty sad!Note: Appearance here is not to suggest I see any credibility or value in what follows. I will leave it to the reader to decide what is worthwhile and what is not! The point is to let people know what is being said / published that I have come upon.-----h...
Source: Australian Health Information Technology - August 23, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs
Featured Health IT Job: Marketing Content Writer
We like to regularly feature a healthcare IT job that might be of interest to readers. Today, we’re featuring the Marketing Content Writer position that was recently posted on Healthcare IT Central. This position was posted by Genzeon and is a Remote Position.
Here’s a description of the position:
The Marketing Content Writer will be primarily responsible for content creation, helping us to bring social posts, case studies, eBooks, blog posts, white papers, video scripts, and articles to our audiences. The Marketing Content Writer will also help develop and enhance our Brand Voice that we use throughout our Ma...
Source: EMR and HIPAA - July 27, 2022 Category: Information Technology Authors: Health IT Jobs Tags: Career and Jobs Healthcare IT Genzeon Jobs Health IT Jobs Healthcare IT Jobs Healthcare Writer Jobs HITMC Jobs Job Seekers Source Type: blogs
Janssen Presents Study Results Showing Clinical Efficacy for TREMFYA ® (guselkumab) and Long-Term Safety Profile for STELARA® (ustekinumab) for Patients Living with Inflammatory Bowel Disease at Digestive Disease Week® 2022
SPRING HOUSE, PENNSYLVANIA, May 24, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 2 GALAXI 1 clinical trial of TREMFYA® (guselkumab) in adult patients with moderately to severely active Crohn’s disease (CD), and from three separate long-term pooled analyses of adult patients with ulcerative colitis (UC) and CD treated with STELARA® (ustekinumab).1,2,3,4 These data are being presented as oral and poster presentations and are among 29 Janssen abstracts presented during the Digestive Disease Week® (DDW) meeting taking place in person and virtually in San Di...
Source: Johnson and Johnson - May 24, 2022 Category: Pharmaceuticals Source Type: news
Biosimilars: A Comparative Study of Regulatory, Safety and Pharmacovigilance Monograph in the Developed and Developing Economies
This article reviews the biosimilars development from the beginning (historic) to the end (development & marketing approval perspectives) and then tries to present a clear picture on areas that are still uncertain concerning the biosimilars landscape especially the biologics effect on immunogenicity, the provocative issue of interchangeability, and extrapolation of indications.PMID:35439428 | DOI:10.18433/jpps32433
Source: J Pharm Pharm Sci - April 19, 2022 Category: Drugs & Pharmacology Authors: Zarina Iqbal Saima Sadaf Source Type: research
